A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo

Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
12/2002
12/03/2002	CA2100974C Layered mixed metal hydroxides for the stabilization of radioactive colloids
11/2002
11/28/2002	WO2002094879A1 Antibodies specific for cd44v6
11/28/2002	WO2002094873A2 Preparation of cholecystokinin agonists and antagonists, and their therapeutic and diagnostic use
11/28/2002	WO2002094217A1 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
11/28/2002	WO2002073235A3 Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy
11/28/2002	WO2002067859A3 Ascorbic acid analogs for metalloradiopharmaceuticals
11/28/2002	WO2002057741A3 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc)
11/28/2002	WO2002024924A3 Protein phosphatases
11/28/2002	US20020176823 Use as diagnostic agents and therapeutic agents
11/28/2002	US20020176819 Gastrin receptor-avid peptide conjugates
11/28/2002	US20020176818 Radionuclide complexed with a chelating agent such as macrocyclic aminophosphonic acid
11/28/2002	DE10123505A1 New immunoconjugate comprising egg yolk immunoglobulin Y, useful for treating e.g. inflammation or infection, is derived from specific pathogen-free hens
11/28/2002	CA2447600A1 Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
11/28/2002	CA2443437A1 Antibodies specific for cd44v6
11/27/2002	EP1259815A1 Immunoassay method for the diagnosis of gastric intestinal metaplasia associated with gastric carcinoma
11/27/2002	EP1259814A1 Bcmp-7 as marker for diagnosis of breast cancer
11/27/2002	EP1259647A2 Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes
11/27/2002	EP1259604A1 Bcmp 84, a protein associated to breast cancer
11/27/2002	EP1259595A2 Integrin antagonists
11/27/2002	EP1259548A1 Antibody specific for the ed-b domain of fibronectin, conjugates comprising said antibody, and their use for the detection and treatment of angiogenesis
11/27/2002	EP1259264A2 Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation
11/27/2002	EP1259255A1 Pai-2 conjugates for the treatment and imaging of cancer
11/27/2002	EP1259237A1 Treatment or prevention of prostate cancer with a cox-2 selective inhibiting drug
11/27/2002	EP1028758A4 Methods for treating prostate tumors using radioactive compositions
11/27/2002	EP1028757A4 Radioactive embolizing compositions
11/26/2002	CA2060330C Compositions and method for soft tissue tumors
11/25/2002	CA2348831A1 Method for preparing technetium- and rhenium-carborane complexes for radioimaging and radiotherapy
11/21/2002	WO2002092782A2 Diagnosis and treatment of malignant neoplasms
11/21/2002	WO2002092771A2 Specific binding proteins and uses thereof
11/21/2002	WO2002092136A2 Immunoconjugates made of egg-yolk antibodies (igy), production and use thereof in diagnoses and therapy
11/21/2002	WO2002092135A1 Methods of using labelled verotoxin b subunit
11/21/2002	WO2002092127A1 Anti-cd26 monoclonal antibodies as therapy for diseases associated with cells expressing cd26
11/21/2002	WO2002092005A2 Stabilization of radionuclide-containing compositions
11/21/2002	WO2002057290A3 Novel fibronectin epitopes and proteinaceous molecules capable of binding said epitopes
11/21/2002	WO2002044217A3 Humanised antibodies and uses thereof
11/21/2002	US20020173618 SSTR1-selective analogs
11/21/2002	US20020172711 Fusogenic liposome formulation for delivering a liposome-entrapped compound into the cytoplasm of a target cell
11/21/2002	CA2826627A1 Specific binding proteins and uses thereof
11/21/2002	CA2448077A1 Stabilization of radionuclide-containing compositions
11/21/2002	CA2447287A1 Immunoconjugates made of egg-yolk antibodies (igy), production and use thereof in diagnoses and therapy
11/21/2002	CA2447139A1 Specific binding proteins and uses thereof
11/21/2002	CA2446806A1 Anti-cd26 monoclonal antibodies as therapy for diseases associated with cells expressing cd26
11/20/2002	EP1257827A1 Diagnosis of breast cancer using bcmp-11 as marker
11/20/2002	EP1257575A1 Radiolabeled vasoactive intestinal peptide analogs for diagnosis and radiotherapy
11/20/2002	EP1257549A2 Matrix metalloproteinase inhibitors and uses thereof
11/20/2002	EP1257299A2 Radioactive therapeutic liposomes
11/20/2002	EP1257285A2 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer
11/20/2002	EP1257268A2 Diagnostic and therapeutic compositions and methods for affecting tumor growth using oxygen mimetic agents
11/20/2002	EP1017684B1 Contrasting agent for infarct and necrosis imaging
11/20/2002	EP0988634A4 PROCESS AND APPARATUS FOR PRODUCTION OF Bi-213 CATIONS
11/19/2002	US6482586 Hybrid compositions for intracellular targeting
11/18/2002	WO2001082979A1 Preparations for evaluating eliminative ability of stomach
11/18/2002	CA2409223A1 Preparations for evaluating eliminative ability of stomach
11/14/2002	WO2002089915A1 Combination x-ray radiation and drug delivery devices and methods for inhibiting hyperplasia
11/14/2002	WO2002089899A1 Combination ionizing radiation and radiosensitizer or immunomodulator delivery devices and methods for inhibiting hyperplasia
11/14/2002	WO2002089771A1 Liposomes
11/14/2002	WO2002007782A3 Diagnosis of liver disease
11/14/2002	WO1999051299A3 Radioactive composition for fabrication of implanted device
11/14/2002	US20020169353 Radioactively coated devices
11/14/2002	US20020169292 Human glycoprotein hormone for use in the prevention and treatment of metabolic and sexual disorders
11/14/2002	US20020169169 5-aminoalkyl and 5-aminocarbonyl substituted indole derivative useful for treatment of psychosis in a mammal
11/14/2002	US20020168375 Biosynthetic binding proteins for immuno-targeting
11/14/2002	US20020168348 Prolonging the acceptance of a graft by administering a short course of an immunosuppressant
11/14/2002	US20020168320 Site specific binding system, imaging compositions and methods
11/14/2002	US20020168319 For providing local radiotherapy for therapy of tumor and arterio-venous malformations in a blood vessel
11/14/2002	US20020168317 Catheter for in vivo detection of nuclear or fluorescent radiation emitted from tagged biological tissue within a human body
11/13/2002	EP1255570A2 Matrix metalloproteinase inhibitors as targeting components in diagnostic agents
11/13/2002	EP0966428B1 PROCESS FOR THE CRYSTALLIZATION FROM A LINEAR OR BRANCHED (C5-C6) ALCOHOL OR THEIR MIXTURES OF (S)-N,N'-bis 2-HYDROXY-1- (HYDROXYMETHYL)ETHYL]-5- (2-HYDROXY-1-OXOPROPYL)AMINO]-2,4,6- TRIIODO-1,3-BENZENEDICARBOXAMIDE
11/13/2002	EP0756496B1 Dendrimeric compounds
11/12/2002	US6479032 Calcitonin receptor binding reagents
11/12/2002	CA2138647C Radioactively-labeled somatostatin-derived peptides for imaging and therapeutic uses
11/07/2002	WO2002088316A2 G-protein coupled receptors
11/07/2002	WO2002088095A1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf)
11/07/2002	WO2002087633A1 Myocardial imaging agent and preparation method thereof
11/07/2002	WO2002087631A1 Gastrin-receptor-avid peptide conjugates
11/07/2002	WO2002087630A2 Determination of gastric and oesophageal tumours
11/07/2002	WO2002087498A2 Diagnostic imaging compositions, their methods of synthesis and use
11/07/2002	WO2002087497A2 Therapeutic agent/ligand conjugate compositions, their methods of synthesis and use
11/07/2002	WO2002087424A2 Treatment and diagnosis of macrophage mediated disease
11/07/2002	WO2002058775A3 Device for dilating and irradiating a vascular segment or body passageway
11/07/2002	US20020165520 Combination ionizing radiation and radiosensitizer delivery devices and methods for inhibiting hyperplasia
11/07/2002	US20020165424 Combination ionizing radiation and immunomodulator delivery devices and methods for inhibiting hyperplasia
11/07/2002	US20020165423 Combination x-ray radiation and drug delivery devices and methods for inhibiting hyperplasia
11/07/2002	US20020165193 Compositions and methods of treating tumors
11/07/2002	US20020165179 Multifunctional nanodevice platform
11/07/2002	US20020164648 Injection of chemical intermediates into mammalian cells; obtain cells, inject with ligand joined colloid, detect signal from ligand
11/07/2002	US20020164339 Recombinant peptides derived from the Mc3 anti-BA46 antibody, methods of use thereof, and methods of humanizing antibody peptides
11/07/2002	US20020164302 Vasopermeability enhancing peptide of human interleukin-2 and immunoconjugates thereof
11/07/2002	US20020164289 Medical diagnosis
11/07/2002	CA2446514A1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf)
11/07/2002	CA2445826A1 Treatment and diagnosis of macrophage mediated disease
11/07/2002	CA2445338A1 G-protein coupled receptors
11/07/2002	CA2444483A1 Diagnostic imaging compositions, their methods of synthesis and use
11/07/2002	CA2444383A1 Therapeutic agent/ligand conjugate compositions, their methods of synthesis and use
11/06/2002	EP1254229A1 Vector constructs for gene-therapy mediated radionuclide therapy of undifferentiated and medullary thyroid carcinomas and non-thyroidal tumours and the metastases thereof
11/06/2002	EP1253928A2 Novel haptotactic peptides
11/06/2002	EP0711300B1 2-pyridylmethylenepolyazamacrocyclophosphonic acids, complexes and derivatives thereof, for use as contrast agents
11/06/2002	EP0630264B1 Ligands for improving metal chelate formation kinetics
11/06/2002	EP0623134B1 Metal complexes of water soluble texaphyrins
11/06/2002	CN1378459A Treatment of auto immune diseases with antagonists which bind to B cell surface markers

1 ... 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 ... 243